Aveanna Healthcare Holdings, Inc.
AVAH- Exchange
- Nasdaq
- Industry
- Services-Home Health Care Services
- SEC CIK
- 0001832332
In the last 90 days, Aveanna Healthcare Holdings, Inc. insiders filed 0 open-market purchases and 5 sales; 217 institutions reported holding it in 13F filings for Q2 2026, worth $1.73B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 2:34 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Jan 3, 2026 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 14, 2026 | Mar 13, 2025 | Mar 14, 2024 | Mar 16, 2023 | Mar 28, 2022 |
| Revenue | $2.43B | $2.02B | $1.90B | $1.79B | $1.68B |
| Gross profit | $810.5M | $635.5M | $595.4M | $553.2M | $542.4M |
| Selling, general and administrative | $374.5M | $352.8M | $361.0M | $357.2M | $297.4M |
| Operating income | $256.5M | $139.8M | $8.07M | -$642.3M | -$36.1M |
| Interest expense | $140.1M | $156.6M | $153.2M | $107.7M | $68.9M |
| Income tax | -$118.1M | $16.0M | -$4.47M | -$1.78M | $3.47M |
| Net income | $225.0M | -$10.9M | -$134.5M | -$662.0M | -$117.0M |
| EPS, basic | $1.11 | $-0.06 | $-0.71 | $-3.57 | – |
| EPS, diluted | $1.05 | $-0.06 | $-0.71 | $-3.57 | – |
| Weighted shares, basic | 203.5M | 192.9M | 190.0M | 185.6K | – |
| Weighted shares, diluted | 215.0M | 192.9M | 190.0M | 185.6K | – |
| Margins and growth | |||||
| Gross margin | 33.3% | 31.4% | 31.4% | 30.9% | 32.3% |
| Operating margin | 10.5% | 6.9% | 0.4% | -35.9% | -2.2% |
| Net margin | 9.2% | -0.5% | -7.1% | -37.0% | -7.0% |
| Revenue growth, year over year | +20.2% | +6.8% | +6.0% | +6.5% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Jan 3, 2026 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 14, 2026 | Mar 13, 2025 | Mar 14, 2024 | Mar 16, 2023 | Mar 28, 2022 |
| Cash and equivalents | $193.3M | $84.3M | $43.9M | $19.2M | $30.5M |
| Accounts receivable | $313.4M | $265.2M | $236.6M | $221.2M | $218.9M |
| Total current assets | $560.2M | $392.7M | $314.9M | $269.8M | $279.2M |
| Property, plant and equipment | $16.7M | $17.4M | $20.5M | $22.8M | $31.4M |
| Goodwill | $1.12B | $1.05B | $1.05B | $1.16B | $1.84B |
| Intangible assets | $92.6M | $89.6M | $94.0M | $95.9M | $102.9M |
| Total assets | $2.01B | $1.66B | $1.61B | $1.71B | $2.33B |
| Short-term debt | $13.3M | $9.20M | $9.20M | $9.20M | $8.60M |
| Total current liabilities | $424.5M | $402.2M | $354.8M | $326.5M | $344.8M |
| Long-term debt | $1.29B | $1.27B | $1.28B | $1.28B | $1.23B |
| Total liabilities | $1.82B | $1.79B | $1.74B | $1.72B | $1.70B |
| Shareholders' equity | $194.5M | -$123.6M | -$129.6M | -$6.31M | $635.8M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Jan 3, 2026 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 14, 2026 | Mar 13, 2025 | Mar 14, 2024 | Mar 16, 2023 | Mar 28, 2022 |
| Operating cash flow | $125.9M | $32.6M | $22.7M | -$48.4M | -$11.3M |
| Capital expenditures | – | – | – | – | $15.9M |
| Free cash flow | – | – | – | – | -$27.3M |
| Depreciation and amortization | $10.5M | $10.8M | $13.8M | $21.3M | $20.6M |
| Stock-based compensation | $25.1M | $17.5M | $13.2M | $15.9M | $14.4M |
| Investing cash flow | -$22.3M | -$6.32M | -$8.79M | -$25.3M | -$681.8M |
| Financing cash flow | $5.41M | $14.0M | $10.8M | $62.4M | $586.3M |
| Net change in cash | $109.0M | $40.3M | $24.7M | -$11.3M | -$106.9M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.0% | 0.9% | 0.7% | 0.9% | 0.9% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Aug 7, 2026 | 218.2M | +4.5% | SEC |
| May 8, 2026 | 217.8M | +11.6% | SEC |
| Mar 13, 2026 | 217.5M | +11.5% | SEC |
| Oct 31, 2025 | 208.9M | +8.1% | SEC |
| Aug 1, 2025 | 208.9M | +8.1% | SEC |
| May 2, 2025 | 195.1M | +1.4% | SEC |
| Mar 7, 2025 | 195.1M | +1.4% | SEC |
| Nov 1, 2024 | 193.2M | +1.3% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.